Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Amicus Reports Additional Trial Data
By: MarketMinute.com Stock News
Posted on February 15, 2013 at 16:05 PM EST

Amicus Therapeutics Inc. (Nasdaq: FOLD) reported additional interim results from an ongoing Phase 3 study of its Fabry disease treatment. The stock price plunged $1.00 to close at $2.89.



Related Stocks:
Amicus Therapeutics, Inc.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here